Allistair Booth is a Partner at Fasken Martineau LLP and is a member of the Technology and Intellectual Property and Life Sciences practice groups.
Allistair has been providing commercial, regulatory and intellectual property advice to companies in that sector since 1997. Prior to joining Fasken Martineau, Allistair had specialised in intellectual property law for 10 years. He is on the Finance and Taxation Advisory Committee of the BioIndustry Association and, along with Stuart Richards, is the firm's representative to BioLegis, its European wide network of life sciences specialist law firms.
Allistair has extensive experience with substantial, often pivotal, licensing transactions, product sales and purchases, strategic product development and life cycle management advice and large scale outsourcing (particularly contract manufacture). Allistair regularly lectures on product life cycle management strategies and outsourcing of manufacturing.
Honours and Awards
- Recommended in Intellectual Asset Management (IAM) magazine's 'Patent 1000: The World’s Leading Patent Practitioners' (2012 edition)
- Recognised by Chambers UK as a 'Leader in their field' within 'Life Sciences: Transactional UK-wide'; Allistair is praised by clients for going "out of his way to understand our company's needs and strategy, always turning things round quickly" (2012 edition)
- Recommended by Intellectual Asset Management (IAM) magazine as one of the top 250 patent and technology licensing lawyers worldwide. Clients praise him for being "extremely responsive and understanding of business priorities" and his "broad skill set enables him to offer an all-embracing service in licensing" (2011/2012 edition)
- Recognised by Legal 500 for his expertise in the fields of 'Pharmaceuticals and Biotechnology' and 'Intellectual Property'. Clients praise the "high-quality, pragmatic and useable advice" (2011 edition)
- Recognised by Legal Experts as an authority in Intellectual Property (2010-2011 editions)
- Recognised by Legal 500 as "excellent" and "spot on with his guidance" within the field of 'TMT - Pharmaceuticals & Biotechnology'. Clients state that "response time is exceptional and more important is the thoroughness and completeness of the response". "Overall, the service is excellent" (2010 edition)
- Recognised by Intellectual Asset Management (IAM) magazine as one of the top 250 patent and technology licensing lawyers worldwide. Allistair is highlighted "as a strategically astute adviser on the most sophisticated transactions" (2010/2011 edition)
Membership/Affiliations
- BioIndustry Association (BIA)
- Association of the British Pharmaceutical Industry (ABPI)